netFormulary Portsmouth and South East Hampshire NHS
Prescribing Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.08.02  Expand sub section  Oral anticoagulants
Edoxaban (Lixiana)
(Tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green

Stroke prevention in non-valvular AF

 

DVT and PE treatment and secondary prevention

 
Warfarin
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green
 
Acenocoumarol (Sinthrome)
(tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Initiation
 
   
Apixaban (Eliquis)
(Tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

VTE prophylaxis following elective hip and knee replacement (full course to be supplied by hospital)


Stroke prevention in non-valvular AF


DVT and PE treatment and secondary prevention

 
Link  NICE TA245 - Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults
Link  NICE TA275 - Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation
Link  NICE TA341 - DVT and PE treatment and secondary prevention
   
Dabigatran (Pradaxa)
(Capsules)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

VTE Prophylaxis following elective hip and knee replacement (full course to be supplied by hospital).


Stroke prevention in non-valular AF


DVT and PE treatment and secondary prevention

 
Link  NICE TA157 - Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
Link  NICE TA249: Dabigatran for Stroke prevention in AF
Link  NICE TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
   
Rivaroxaban (Xarelto)
(Tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

 VTE following elective hip and knee replacement - FULL COURSE SUPPLIED BY HOSPITAL

 
Link  NICE TA170 - Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
   
Rivaroxaban (Xarelto)
(Tablets )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Stroke prevention in non-valvular AF


DVT treatment and secondary prevention


PE treatment and secondary prevention

 
Link  NICE TA256 - Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
Link  NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Link  NICE TA287 - Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism
   
Rivaroxaban (Xarelto)
(Tablets 2.5mg)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Initiation

Post ACS with antiplatelet

 
Link  NICE TA335 - Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
Link  NICE TA607 Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
   
Warfarin 5mg in 5ml
(oral suspension)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Initiation

Paediatrics only

 
   
02.08.02  Expand sub section  Atrial Fibrillation
02.08.02  Expand sub section  VTE treatment
02.08.02  Expand sub section  VTE prophylaxis in hip/knee surgery
02.08.02  Expand sub section  VTE Prophylaxis to top
 ....
 Non Formulary Items
Phenindione

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Primary and Secondary Care (unrestricted) may be prescribed by GPs, hospital doctors or other qualified prescribers in primary and secondary care  

Amber Initiation

Amber Initiated: first prescription from specialist, on going supplies from primary care (or when stabilised on therapy).  

Amber Recommended

Amber recommended: first prescription may be supplied by primary care under the advice of a specialist.  

Amber with Shared Care

For initiation within a specialist service followed by ongoing prescribing in primary care according to published shared care guidance  

Red

For initiation and ongoing prescribing in secondary care only. Medicines in this category may be further restricted to use by specific hospital departments only.  

Blue

For prescribing in primary care only  

netFormulary